Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have requested a re-examination of the recent negative opinion issued by the ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Third quarter 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 millionRaises full year 2025 global revenue ...

Cats lack certain enzymes to properly metabolize essential oils ... or blinking. Additionally, allergic reactions or skin ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

Sleepless nights haunt millions, yet a quiet shift in bedside habits hints at relief hiding in plain sight. From pharmacy counters to workplace chats, ...

Indivior PLC  presented three new scientific posters at the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference last week, showcasing real-world evidence on the clinical and economic impact ...

A major new national facility for electron microscopy, called EMPower, has been awarded to a consortium of Dutch universities and medical centers. EMPower aims to pave the way for major discoveries ...

Hydrolyzable tannins (HTs), including gallotannins and ellagitannins, are essential polyphenolic compounds that influence ...